↓ Skip to main content

Glycine transporter 1 is a target for the treatment of epilepsy

Overview of attention for article published in Neuropharmacology, August 2015
Altmetric Badge

About this Attention Score

  • Average Attention Score compared to outputs of the same age

Mentioned by

twitter
1 X user

Readers on

mendeley
106 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Article details
Title
Glycine transporter 1 is a target for the treatment of epilepsy
Published in
Neuropharmacology, August 2015
DOI 10.1016/j.neuropharm.2015.08.031
Pubmed ID
Authors

Login to access the Attention Digest and the Sentiment Analysis related to this output.

Timeline Attention over time Attention Score history
Login to access the full charts related to this output.
Activity
Login to access the full charts related to this output.
X Demographics

X Demographics

The data shown below were collected from the profile of 1 X user who shared this research output. Click here to find out more about how the information was compiled.
Mendeley demographics

Mendeley demographics

The data shown below were compiled from readership statistics for 106 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Login to view Mendeley reader trends over time.

Geographical breakdown

Geographical breakdown
Country Count As %
Unknown 106 100%

Demographic breakdown

Readers by professional status
Readers by professional status Count As %
Student > Bachelor 15 14%
Student > Master 14 13%
Student > Ph. D. Student 12 11%
Researcher 11 10%
Other 6 6%
Other 16 15%
Unknown 32 30%
Readers by discipline
Readers by discipline Count As %
Neuroscience 17 16%
Medicine and Dentistry 14 13%
Biochemistry, Genetics and Molecular Biology 10 9%
Agricultural and Biological Sciences 10 9%
Pharmacology, Toxicology and Pharmaceutical Science 4 4%
Other 16 15%
Unknown 35 33%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 1. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 16 October 2015.
All research outputs
#17,286,379
of 25,374,647 outputs
Outputs from Neuropharmacology
#3,562
of 4,817 outputs
Outputs of similar age
#166,655
of 277,680 outputs
Outputs of similar age from Neuropharmacology
#54
of 85 outputs
Altmetric has tracked 25,374,647 research outputs across all sources so far. This one is in the 21st percentile – i.e., 21% of other outputs scored the same or lower than it.
So far Altmetric has tracked 4,817 research outputs from this source. They typically receive more attention than average, with a mean Attention Score of 8.1. This one is in the 18th percentile – i.e., 18% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 277,680 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 31st percentile – i.e., 31% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 85 others from the same source and published within six weeks on either side of this one. This one is in the 28th percentile – i.e., 28% of its contemporaries scored the same or lower than it.